Iovance Biotherapeutics, Inc.

Applications for our next partnership with Iovance Biotherapeutics, Inc. and Navy Yard Philadelphia close tomorrow at 5 PM! Please share this opportunity with anyone in your network who would be a good fit.

We're now accepting applications for our next cohort with Iovance Biotherapeutics, Inc., built in partnership with Navy Yard Philadelphia! This program prepares graduates with workplace and technical skills to be successful in the life science industry, including college-adapted coursework provided by Community College of Philadelphia. Through this program, graduates will be prepared to connect to Aseptic Manufacturing Technician roles with Iovance Biotherapeutics where they will support the production of cell therapies to treat disease. Interested applicants can learn more using this link: https://lnkd.in/gGjepx45

At Iovance, we recognize and celebrate the pivotal role women play in advancing science and innovation. #womeninbiotech #womenshistorymonth #womeninSTEM

We are honored to receive the 2024 Patient Impact Award from Life Sciences Pennsylvania! Our Interim CEO Fred Vogt recently joined LSPA's "Being a Life Sciences Leader" podcast series to describe the Iovance journey and our dedication to cancer patients. https://lnkd.in/e4ACWtx7

Today Iovance reported fourth quarter and full year 2024 financial results and corporate updates. We will host an audio webcast at 4:30 pm ET, join live or listen to the replay: https://lnkd.in/e_Nn7dpU

Please join us in welcoming Dan Kirby to Iovance in the newly created role of Chief Commercial Officer: https://lnkd.in/eFyABiMV

This Black History Month, we honor pioneering African American dermatologists who paved the way for equitable skin health research. Dr. Theodore K. Lawless, Dr. John A. Kenney Jr., and Dr. A. Paul Kelly broke barriers and advanced dermatological care for all. Their groundbreaking work reminds us that diversity in medicine is crucial for progress. Join us in celebrating these trailblazers and continuing their mission. By supporting diverse voices in dermatology, we accelerate scientific discovery and improve outcomes for all melanoma patients. Together, we can ensure everyone receives the best care, regardless of race. #BlackHistoryMonth #DiversityInDermatology #MelanomaResearch #EquitableHealthcare

Iovance is ready for an exciting 2025! We continue to expect significant growth in line with our full-year revenue guidance for 2024 and 2025. Check out our latest corporate presentation: https://lnkd.in/eXHK4FxH

Our next Iovance cohort begins this evening! Built in partnership with The Wistar Institute and Navy Yard Philadelphia, this program kicks off with 10 weeks of in-person classes followed by 2 weeks of lab training at The Wistar Institute before participants transition to externships with Iovance. Join us in wishing the best of luck to the 12 participants who begin their training to start the new year! 

Meet Robeal Russom in this latest video highlighting the impact of the Good Jobs Challenge. Robeal is a graduate of a 2024 partnership between ourselves, The Wistar Institute, and Navy Yard Philadelphia for roles with Iovance Biotherapeutics, Inc. This video is part of a series produced by Philadelphia Works, Inc.